Correction: Selective Targeting of CTNNB1-, KRAS- Or MYC-Driven Cell Growth by Combinations of Existing Drugs

PLoS ONE - United States
doi 10.1371/journal.pone.0132230
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Public Library of Science (PLoS)

Related search

Selective Targeting of Point-Mutated KRAS Through Artificial microRNAs

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Pharmacological Targeting of MYC-regulated IRE1/XBP1 Pathway Suppresses MYC-driven Breast Cancer

Journal of Clinical Investigation
Medicine
2018English

Selective Targeting of KRAS Oncogenic Alleles by CRISPR/Cas9 Inhibits Proliferation of Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Selective Tissue Targeting of Synthetic Nucleic Acid Drugs

Journal of Clinical Investigation
Medicine
2019English

Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2018English

miRNA-145 Inhibits Non-Small Cell Lung Cancer Cell Proliferation by Targeting C-Myc

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2010English

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Mean Field Analysis of Orientation Selective Grain Growth Driven by Interface-Energy Anisotropy

Materials Research Society Symposium - Proceedings
Mechanics of MaterialsMaterials ScienceCondensed Matter PhysicsMechanical Engineering
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy